Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA.

IF 2.1 4区 医学 Q2 PSYCHOLOGY, CLINICAL
Journal of psychoactive drugs Pub Date : 2024-07-01 Epub Date: 2023-06-29 DOI:10.1080/02791072.2023.2227960
Nancy A Haug, Richa Wadekar, Rachel Barry, James Sottile
{"title":"Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA.","authors":"Nancy A Haug, Richa Wadekar, Rachel Barry, James Sottile","doi":"10.1080/02791072.2023.2227960","DOIUrl":null,"url":null,"abstract":"<p><p>Ecstasy/Molly/MDMA is a widely used substance often taken in combination with other drugs in different contexts. The current study assessed ecstasy use patterns, concurrent substance use and the context of ecstasy use among an international sample of adults (<i>N</i> = 1,732). Participants were 87% white, 81% male, 42% college educated, 72% employed, with a mean age of 25.7 (<i>SD</i> = 8.3). Using the modified UNCOPE, risk for ecstasy use disorder was 22% overall, and significantly higher among younger individuals and those with greater frequency and quantity of use. Participants reporting risky ecstasy use endorsed significantly higher use of alcohol, nicotine/tobacco, cannabis, cocaine, amphetamine, benzodiazepines, and ketamine compared to those at lower risk. Great Britain (aOR = 1.86; 95% CI [1.24, 2.81]) and Nordic countries (aOR = 1.97; 95% CI [1.11, 3.47]) were approximately 2 times more likely to exhibit risk for ecstasy use disorder than the United States, Canada, Germany, and Australia/New Zealand. Taking ecstasy at home emerged as a common setting followed by electronic dance music events and music festivals. The UNCOPE may be a useful clinical tool for detecting problematic ecstasy use. Harm reduction interventions for ecstasy should target young people, substance co-administration, and context of use.</p>","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"412-421"},"PeriodicalIF":2.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of psychoactive drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/02791072.2023.2227960","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Ecstasy/Molly/MDMA is a widely used substance often taken in combination with other drugs in different contexts. The current study assessed ecstasy use patterns, concurrent substance use and the context of ecstasy use among an international sample of adults (N = 1,732). Participants were 87% white, 81% male, 42% college educated, 72% employed, with a mean age of 25.7 (SD = 8.3). Using the modified UNCOPE, risk for ecstasy use disorder was 22% overall, and significantly higher among younger individuals and those with greater frequency and quantity of use. Participants reporting risky ecstasy use endorsed significantly higher use of alcohol, nicotine/tobacco, cannabis, cocaine, amphetamine, benzodiazepines, and ketamine compared to those at lower risk. Great Britain (aOR = 1.86; 95% CI [1.24, 2.81]) and Nordic countries (aOR = 1.97; 95% CI [1.11, 3.47]) were approximately 2 times more likely to exhibit risk for ecstasy use disorder than the United States, Canada, Germany, and Australia/New Zealand. Taking ecstasy at home emerged as a common setting followed by electronic dance music events and music festivals. The UNCOPE may be a useful clinical tool for detecting problematic ecstasy use. Harm reduction interventions for ecstasy should target young people, substance co-administration, and context of use.

国际摇头丸/摇头丸/二亚甲基双氧安非他明娱乐使用者中摇头丸使用障碍和其他物质使用的风险。
摇头丸/摇头丸/二亚甲基双氧安非他明是一种广泛使用的药物,在不同情况下经常与其他药物混合使用。本研究对国际成人样本(样本数 = 1,732)中摇头丸的使用模式、同时使用的药物和使用摇头丸的背景进行了评估。参与者中 87% 为白人,81% 为男性,42% 受过大学教育,72% 有工作,平均年龄为 25.7 岁(SD = 8.3)。使用修改后的 UNCOPE,摇头丸使用障碍的总体风险为 22%,在年轻人以及使用频率和数量较高的人群中风险明显较高。与风险较低者相比,报告有使用摇头丸风险的参与者对酒精、尼古丁/烟草、大麻、可卡因、苯丙胺、苯二氮卓和氯胺酮的使用明显较高。与美国、加拿大、德国和澳大利亚/新西兰相比,英国(aOR = 1.86;95% CI [1.24,2.81])和北欧国家(aOR = 1.97;95% CI [1.11,3.47])出现摇头丸使用障碍风险的可能性大约高出 2 倍。在家中服用摇头丸是一种常见的情况,其次是电子舞曲活动和音乐节。UNCOPE 可能是检测问题摇头丸使用情况的有用临床工具。针对摇头丸的减低危害干预措施应以年轻人、共同使用药物和使用环境为目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
7.10%
发文量
62
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信